help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berry, M. J.
Right arrow Articles by Larsen, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berry, M. J.
Right arrow Articles by Larsen, P. R.

Endocrinology, Vol 129, 550-552, Copyright © 1991 by Endocrine Society


ARTICLES

Evidence that cysteine, not selenocysteine, is in the catalytic site of type II iodothyronine deiodinase

MJ Berry, JD Kieffer and PR Larsen
Department of Medicine, Brigham and Women's Hospital, Boston.

Recent cloning of the cDNA for Type I iodothyronine deiodinase revealed that the mRNA contains a UGA codon encoding the amino acid selenocysteine. Mutagenesis of the selenocysteine codon to a cysteine codon produced a protein with lower deiodinase activity. The presence or absence of selenocysteine in Type II deiodinase, which differs from the Type I enzyme in a number of parameters, has not been determined. Gold inhibits the activity of both the Type I deiodinase and the only other known eukaryotic selenocysteine-enzyme, glutathione peroxidase. Substitution of cysteine for selenocysteine in Type I deiodinase reduced its sensitivity to inhibition by gold 500-fold. We found that gold thioglucose was a competitive inhibitor with respect to the iodothyronine substrate of both deiodinases. However, the Type II enzyme from brown fat and pituitary was 100 to 1000-fold less sensitive to gold than was Type I activity in liver and pituitary, similar to the results with the cysteine-substituted Type I enzyme. This suggests that Type II deiodinase contains cysteine instead of selenocysteine in the active site.


This article has been cited by other articles:


Home page
J. Bacteriol.Home page
F. Peters, M. Rother, and M. Boll
Selenocysteine-Containing Proteins in Anaerobic Benzoate Metabolism of Desulfococcus multivorans
J. Bacteriol., April 1, 2004; 186(7): 2156 - 2163.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Montero-Pedrazuela, J. Bernal, and A. Guadano-Ferraz
Divergent Expression of Type 2 Deiodinase and the Putative Thyroxine-Binding Protein p29, in Rat Brain, Suggests that They Are Functionally Unrelated Proteins
Endocrinology, March 1, 2003; 144(3): 1045 - 1052.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
M. Rother, I. Mathes, F. Lottspeich, and A. Bock
Inactivation of the selB Gene in Methanococcus maripaludis: Effect on Synthesis of Selenoproteins and Their Sulfur-Containing Homologs
J. Bacteriol., January 1, 2003; 185(1): 107 - 114.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. G. J. M. Kuiper, W. Klootwijk, and T. J. Visser
Substitution of Cysteine for a Conserved Alanine Residue in the Catalytic Center of Type II Iodothyronine Deiodinase Alters Interaction with Reducing Cofactor
Endocrinology, April 1, 2002; 143(4): 1190 - 1198.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen
Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases
Endocr. Rev., February 1, 2002; 23(1): 38 - 89.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Buettner, J. W. Harney, and P. R. Larsen
The Role of Selenocysteine 133 in Catalysis by the Human Type 2 Iodothyronine Deiodinase
Endocrinology, December 1, 2000; 141(12): 4606 - 4612.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. F. Ramos, C. V. Teixeira, M. C. F. Passos, C. C. Pazos-Moura, P. C. Lisboa, F. H. Curty, and E. G. de Moura
Low-Protein Diet Changes Thyroid Function in Lactating Rats
Experimental Biology and Medicine, September 1, 2000; 224(4): 256 - 263.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
B. Gereben, T. Bartha, H. M. Tu, J. W. Harney, P. Rudas, and P. R. Larsen
Cloning and Expression of the Chicken Type 2 Iodothyronine 5'-Deiodinase
J. Biol. Chem., May 14, 1999; 274(20): 13768 - 13776.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Wen, S. L. Weiss, and R. A. Sunde
UGA Codon Position Affects the Efficiency of Selenocysteine Incorporation into Glutathione Peroxidase-1
J. Biol. Chem., October 23, 1998; 273(43): 28533 - 28541.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. P. Sanders, S. Van der Geyten, E. Kaptein, V. M. Darras, E. R. Kuhn, J. L. Leonard, and T. J. Visser
Characterization of a Propylthiouracil-Insensitive Type I Iodothyronine Deiodinase
Endocrinology, December 1, 1997; 138(12): 5153 - 5160.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Safran, A. P. Farwell, and J. L. Leonard
Catalytic Activity of Type II Iodothyronine 5'-Deiodinase Polypeptide Is Dependent upon a Cyclic AMP Activation Factor
J. Biol. Chem., July 5, 1996; 271(27): 16363 - 16368.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Leonard, S. J. Stachelek, M. Safran, A. P. Farwell, T. F. Kowalik, and J. L. Leonard
Cloning, Expression, and Functional Characterization of the Substrate Binding Subunit of Rat Type II Iodothyronine 5'-Deiodinase
J. Biol. Chem., August 11, 2000; 275(33): 25194 - 25201.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society